108 related articles for article (PubMed ID: 31146613)
1. The Novel Effects of a Hydrolyzed Polysaccharide Dietary Supplement on Immune, Hepatic, and Renal Function in Adults with HIV in a Randomized, Double-Blind, Placebo-Control Trial.
Lewis JE; Atlas Bsn SE; Abbas MH; Rasul A; Farooqi A; Lantigua LA; Michaud F; Goldberg S; Lages LC; Higuera OL; Fiallo A; Tiozzo E; Woolger JM; Ciraula S; Mendez A; Rodriguez A; Konefal J
J Diet Suppl; 2020; 17(4):429-441. PubMed ID: 31146613
[TBL] [Abstract][Full Text] [Related]
2. RETRACTED ARTICLE: The Novel Effects of a Hydrolyzed Polysaccharide Dietary Supplement on Immune, Hepatic, and Renal Function in Adults with HIV in a Randomized, Double-Blind Placebo-Control Trial.
Lewis JE; Atlas SE; Abbas MH; Rasul A; Farooqi A; Lantigua LA; Michaud F; Goldberg S; Lages LC; Higuera OL; Fiallo A; Tiozzo E; Woolger JM; Ciraula S; Mendez A; Rodriguez A; Konefal J
J Diet Suppl; 2021; 18(2):I-XIII. PubMed ID: 30346850
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular, endothelial function, and immune markers in response to treatment with a polysaccharide in HIV
Lewis JE; Atlas SE; Abbas MH; Rasul A; Farooqi A; Lantigua LA; Michaud F; Goldberg S; Lages LC; Gao J; Higuera OL; Fiallo A; Harvey PD; Tiozzo E; Woolger JM; Ciraula S; Mendez A; Rodriguez A; Konefal J
J Clin Transl Res; 2020 Apr; 5(3):140-147. PubMed ID: 32637718
[TBL] [Abstract][Full Text] [Related]
4. The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease.
Lewis JE; Atlas SE; Higuera OL; Fiallo A; Rasul A; Farooqi A; Kromo O; Lantigua LA; Tiozzo E; Woolger JM; Goldberg S; Mendez A; Rodriguez AE; Konefal J
Evid Based Complement Alternat Med; 2018; 2018():1751583. PubMed ID: 29853945
[TBL] [Abstract][Full Text] [Related]
5. Effect of the serotonin receptor agonist, buspirone, on immune function in HIV-infected individuals: a six-month randomized, double-blind, placebo-controlled trial.
Eugen-Olsen J; Benfield T; Axen TE; Parner J; Iversen J; Pedersen C; Nielsen JO
HIV Clin Trials; 2000; 1(1):20-6. PubMed ID: 11590486
[TBL] [Abstract][Full Text] [Related]
6. Rice Bran Arabinoxylan Compound and Quality of Life (RBAC-QoL) of Cancer Patients: An Interim Analysis of the RBAC-QoL Study.
Ooi SL; Micalos PS; Zielinski R; Pak SC
Cureus; 2024 Jan; 16(1):e53188. PubMed ID: 38425632
[TBL] [Abstract][Full Text] [Related]
7. The effect of standard dose multivitamin supplementation on disease progression in HIV-infected adults initiating HAART: a randomized double blind placebo-controlled trial in Uganda.
Guwatudde D; Wang M; Ezeamama AE; Bagenda D; Kyeyune R; Wamani H; Manabe YC; Fawzi WW
BMC Infect Dis; 2015 Aug; 15():348. PubMed ID: 26285704
[TBL] [Abstract][Full Text] [Related]
8. The immunomodulatory nutritional intervention NR100157 reduced CD4+ T-cell decline and immune activation: a 1-year multicenter randomized controlled double-blind trial in HIV-infected persons not receiving antiretroviral therapy (The BITE Study).
Cahn P; Ruxrungtham K; Gazzard B; Diaz RS; Gori A; Kotler DP; Vriesema A; Georgiou NA; Garssen J; Clerici M; Lange JM;
Clin Infect Dis; 2013 Jul; 57(1):139-46. PubMed ID: 23511299
[TBL] [Abstract][Full Text] [Related]
9. Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial.
Kaiser JD; Campa AM; Ondercin JP; Leoung GS; Pless RF; Baum MK
J Acquir Immune Defic Syndr; 2006 Aug; 42(5):523-8. PubMed ID: 16868496
[TBL] [Abstract][Full Text] [Related]
10. Rice bran arabinoxylan compound as a natural product for cancer treatment - an evidence-based assessment of the effects and mechanisms.
Ooi SL; Micalos PS; Kim J; Pak SC
Pharm Biol; 2024 Dec; 62(1):367-393. PubMed ID: 38745507
[TBL] [Abstract][Full Text] [Related]
11. Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study).
Serrano-Villar S; de Lagarde M; Vázquez-Castellanos J; Vallejo A; Bernadino JI; Madrid N; Matarranz M; Díaz-Santiago A; Gutiérrez C; Cabello A; Villar-García J; Blanco JR; Bisbal O; Sainz T; Moya A; Moreno S; Gosalbes MJ; Estrada V
Clin Infect Dis; 2019 Jan; 68(1):120-130. PubMed ID: 29788075
[TBL] [Abstract][Full Text] [Related]
12. Impact of dolutegravir and efavirenz on immune recovery markers: results from a randomized clinical trial.
Blanco JR; Alejos B; Moreno S
Clin Microbiol Infect; 2018 Aug; 24(8):900-907. PubMed ID: 29183782
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial of oral zinc on the immune response to tuberculosis in HIV-infected patients.
Green JA; Lewin SR; Wightman F; Lee M; Ravindran TS; Paton NI
Int J Tuberc Lung Dis; 2005 Dec; 9(12):1378-84. PubMed ID: 16466061
[TBL] [Abstract][Full Text] [Related]
14. Dietary supplementation with rice bran fermented with Lentinus edodes increases interferon-γ activity without causing adverse effects: a randomized, double-blind, placebo-controlled, parallel-group study.
Choi JY; Paik DJ; Kwon DY; Park Y
Nutr J; 2014 Apr; 13():35. PubMed ID: 24755139
[TBL] [Abstract][Full Text] [Related]
15. The Health-Promoting Properties and Clinical Applications of Rice Bran Arabinoxylan Modified with Shiitake Mushroom Enzyme-A Narrative Review.
Ooi SL; Pak SC; Micalos PS; Schupfer E; Lockley C; Park MH; Hwang SJ
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925340
[TBL] [Abstract][Full Text] [Related]
16. Differential CD4+ cell count increase and CD4+ : CD8+ ratio normalization with maraviroc compared with tenofovir.
Chan ES; Landay AL; Brown TT; Ribaudo HJ; Mirmonsef P; Ofotokun I; Weitzmann MN; Martinson J; Klingman KL; Eron JJ; Fichtenbaum CJ; Plants J; Taiwo BO
AIDS; 2016 Aug; 30(13):2091-7. PubMed ID: 27281061
[TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial of lovastatin in HIV-infected, HAART naïve patients (NCT00721305).
Montoya CJ; Higuita EA; Estrada S; Gutierrez FJ; Amariles P; Giraldo NA; Jimenez MM; Velasquez CP; Leon AL; Rugeles MT; Jaimes FA
J Infect; 2012 Dec; 65(6):549-58. PubMed ID: 23085245
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.
Nakanjako D; Ssinabulya I; Nabatanzi R; Bayigga L; Kiragga A; Joloba M; Kaleebu P; Kambugu AD; Kamya MR; Sekaly R; Elliott A; Mayanja-Kizza H
Trop Med Int Health; 2015 Mar; 20(3):380-90. PubMed ID: 25441397
[TBL] [Abstract][Full Text] [Related]
19. Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2).
Blanco JR; Alejos B; Moreno S
PLoS One; 2020; 15(1):e0226724. PubMed ID: 31945066
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
